← back to search

Yu Zhang

University of Science and Technology Beijing · CN
🔎 Find collaborators in Cancer Research · Molecular Biology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, MicroRNA in disease regulation, Circular RNAs in diseases, and RNA modifications and cancer.
h-index
59
citations
14,166
works
1,096
NIH funding
primary concept
email

Recent publications

Dermoscopy-guided sampling improves the diagnostic yield of fungal culture for onychomycosis: a comparative study
Frontiers in Medicine 2026cited by 0position: middledoi
Prognostic Nomogram for Ovarian Cancer Patients on First-Line Maintenance Therapy With PARP Inhibitors: A Retrospective Cohort Study.
2026cited by 0position: contributordoi
Ultralight, superior stability and inner hydrophobic cement foam prepared with surface-modified inorganic particles-stabilized bubbles
Materials Letters 2026cited by 0position: middledoi
A novel PDE4A inhibitor suppresses hepatocellular carcinoma progression through activating the cAMP-induced PKA pathway
Chemico-Biological Interactions 2026cited by 0position: middledoi
Bioinspired Glycosylpyridinium Donors for Mild and Stereoselective Glycosylation
JACS Au 2026cited by 0position: middledoi
A microbiota-tryptophol-AhR axis mediates the gut-kidney protective effects of Hushen Tongfengtai Granules in hyperuricemic nephropathy
Phytomedicine 2026cited by 0position: middledoi
Identification and Validation of <scp>miR</scp> ‐206‐3p Targeting <scp>WT</scp> ‐1 Promotes Membranous Nephropathy Through a Comprehensive Bioinformatics and Machine Learning Algorithm
The FASEB Journal 2026cited by 0position: middledoi
Bone marrow mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration by regulating HMGB1 acetylation via SIRT6
Biochemical and Biophysical Research Communications 2026cited by 0position: middledoi
Integrated analysis of phenotypic and SSR data reveals the genetic structure differentiation of wild Rhododendron mariae Hance populations in Guangdong and the driving factors for conservation planning
Frontiers in Plant Science 2026cited by 0position: middledoi
Predictive performance of the SOFA 2.0 score for in-hospital mortality in patients with heat stroke: a multicenter, data-driven subphenotype study
Frontiers in Medicine 2026cited by 0position: middledoi
Revisiting therapeutic options against resistant klebsiella pneumoniae infection: Phage therapy is key
Microbiological Research 2025cited by 14position: middledoi
MLKL as an emerging machinery for modulating organelle dynamics: regulatory mechanisms, pathophysiological significance, and targeted therapeutics
Frontiers in Pharmacology 2025cited by 10position: middledoi
Targeting HPV for the prevention, diagnosis, and treatment of cervical cancer.
2025cited by 8position: contributordoi
Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis: a systematic review and meta-analysis
Frontiers in Pharmacology 2025cited by 8position: lastdoi
Optimizing the Follow-Up Interval After Successful Cold Knife Conization of CIN3: A 10-Year Retrospective Cohort Study.
2025cited by 3position: contributordoi
Effects of maternal blood beta-hydroxybutyrate on brown adipose tissue functions and thermogenic and metabolic health in neonatal calves
Journal of Dairy Science 2025cited by 3position: middledoi
Influence of Pre-Vaccination HPV Status on Vaccine Effectiveness Among Chinese Women: A Multicenter Cross-Sectional Study.
2025cited by 1position: contributordoi
HELQ upregulates PARP1 to drive platinum resistance and predict therapeutic response in ovarian cancer
Translational Oncology 2025cited by 1position: contributordoi
Metabolomic and transcriptomic analyses provide insights into the role of MiMYB114 and MiMYC2 in the MeJA-induced regulatory network for mango pericarp coloration
International Journal of Biological Macromolecules 2025cited by 1position: middledoi
2163P Safety and efficacy of simmitinib in patients(pts) with advanced solid tumors: A phase I study
Annals of Oncology 2025cited by 0position: middledoi
Supplementary Data from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
2025cited by 0position: contributordoi
Figure S.2 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
2025cited by 0position: contributordoi
Figure S.6 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
2025cited by 0position: contributordoi
Figure S.5 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
2025cited by 0position: contributordoi
Figure S.1 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
2025cited by 0position: contributordoi
Figure S.8 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
2025cited by 0position: contributordoi
Figure S.4 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
2025cited by 0position: contributordoi
Figure S.3 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
2025cited by 0position: contributordoi
Figure S.7 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
2025cited by 0position: contributordoi
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
Nature Medicine 2024cited by 34position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 40 papers (2021–2026)Yu Sun · Tongji University30 papers (2022–2025)Jicheng Yue · Binzhou Medical University30 papers (2022–2025)Xing S. Fan · 30 papers (2022–2025)Qian Wu · Elsevier, Inc.30 papers (2022–2025)Xiaju Cheng · Soochow University30 papers (2022–2025)Li-Yan Xu · Hebei North University30 papers (2022–2025)Yuanyuan Zeng · Elsevier, Inc.30 papers (2022–2025)Dazhuan E. Xin · 30 papers (2022–2025)Xufeng Lu · Wenzhou Medical University30 papers (2022–2025)Xue Li · Hangzhou Medical College30 papers (2022–2025)Xiongbing Zu · Xiangya Hospital Central South University30 papers (2022–2025)Juanjuan K. Du · Shanghai Jiao Tong University30 papers (2022–2025)Zhaoyuan Hou · Binzhou University30 papers (2022–2025)Man Mohan · University of Delhi30 papers (2022–2025) · 30 papers (2022–2025)Wenhai Deng · Wenzhou Medical University30 papers (2022–2025)Zhijie Chang · Tsinghua University30 papers (2022–2025)Yanan S. Zhang · 30 papers (2022–2025)Xiaomei Lu · Xinjiang Medical University30 papers (2022–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cancer Research · Molecular Biology →